… A comprehensive study and meta-analysis both concur that cannabis usage is linked to a …
efficacy in different types of neuropathic pain has demanded its commercialization as food with …

… Researchers reported that cannabis-based medicine was effective in reducing pain and
sleep disturbance in patients with multiple sclerosisrelated central neuropathic pain and was …

… , modest evidence for multiple sclerosis related pain, and as adjuvant therapy in cancer …
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. …

… , multiple sclerosis-related spasticity, and epilepsy [8]. … A more recent meta-analysis published
in the BMJ found very … 2.7 mg THC and 2.5 mg CBD Sativex ® UK 125 Neuropathic pain A …

… treatment of refractory spasticity and neuropathic pain in patients suffering from multiple
sclerosis as well as refractory pain … THC treatments in tandem with other pain-relief medications. …

… to reduce neuropathic and chronic pain [23]. The potency of … of a systemic review and
meta-analysis of 22 studies, in which … Sativex in the management of multiple sclerosis-related …

… therapies whose interventions for chronic pain is insufficient to … nerve cells. The advantages
and disadvantages of this other form of therapy, and its potential application for the treatment …

… : Nabiximols oromucosal spray,a cannabis-based medicine containing a balanced ratio of
Δ-… ‐based medicines can be considered as third‐line therapy for chronic neuropathic pain and …

… eicosanoid production and stop the death of nerve cells [137]. Studies … the involvement of
Cannabis in reducing pain, drooling, … review and meta-analysis. JAMA 2015; 313(24): 2456-73. …

… effectiveness and safety of cannabinoid-based therapies in the treatment of various …
CBD as an add-on therapy in children with TREs diminished the frequency of seizures in 84…